Glucagon-like peptide-1 receptor agonist use was associated with increased risk of telogen effluvium and androgenetic alopecia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results